Matthew Pauls's Net Worth
$6.96 Million
Who is Matthew Pauls?
Matthew Pauls has an estimated net worth of $6.96 Million. This is based on reported shares across multiple companies, which include INSMED Inc, Strongbridge Biopharma plc, Zyla Life Sciences, Savara Inc, and SOLENO THERAPEUTICS INC.
SEC CIK
Matthew Pauls's CIK is 0001573429
Past Insider Trading and Trends
2021 was Matthew Pauls's most active year for acquiring shares with 13 total transactions. Matthew Pauls's most active month to acquire stocks was the month of November. 2020 was Matthew Pauls's most active year for disposing of shares, totalling 3 transactions. Matthew Pauls's most active month to dispose stocks was the month of March. 2014 saw Matthew Pauls paying a total of $992,100.00 for 60,000 shares, this is the most they've acquired in one year. In 2023 Matthew Pauls cashed out on 109,680 shares for a total of $488,076.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INSMED Inc (INSM) Snapshot price: $29.075
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Strongbridge Biopharma plc No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +221.16% | 50K |
—
|
—
| 72.61K |
Feb 20
| |||
Form 4
| -43.48% | -17.39K |
$6.60 | -$114,787.20 | 22.61K |
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zyla Life Sciences No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -26.95K |
—
|
—
|
0
|
May 20
| |||
Form 4/A
|
∞
| 4.86K |
$1.75 | $8,508.50 | 4.86K |
Apr 23
| |||
Form 4
|
∞
| 5.71K |
$1.75 | $10,001.25 | 5.71K |
Apr 23
| |||
Form 4
|
∞
| 13.62K |
—
|
—
| 13.62K |
Mar 4
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Savara Inc (SVRA) Snapshot price: $4.715
CHIEF EXECUTIVE OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.43% | -103.00K |
$4.71 | -$395,900.40 | 1.28M |
Dec 28
| |||
Form 4
| +32.52% | 340.32K |
$4.45 | -$488,076.00 | 1.39M |
Dec 14
| |||
Form 4
| +45.05% | 325K |
—
|
—
| 1.05M |
Dec 13
| |||
Form 4
| -7.95% | -62.32K |
$1.24 | -$77,274.32 | 721.35K |
Dec 31
| |||
Form 4
| +104.26% | 400K |
—
|
—
| 783.67K |
Dec 14
| |||
Form 4
| +1.72% | 6.5K |
$1.06 | $6,889.35 | 383.67K |
Dec 8
| |||
Form 4
| +2.72% | 10K |
$1.10 | $10,954.00 | 377.17K |
Dec 2
| |||
Form 4
| +6.42% | 22.15K |
$1.10 | $24,389.75 | 367.17K |
Nov 18 - Nov 19
| |||
Form 4
| +8.46% | 26.9K |
$1.18 | $31,865.76 | 345.02K |
Aug 17 - Aug 18
| |||
Form 4
| +3.25% | 10K |
$1.63 | $16,298.00 | 318.12K |
May 21
| |||
Form 4
| +9.76% | 27.4K |
$1.82 | $49,870.74 | 308.12K |
Scheduled
|
Apr 19
| ||
Form 4
| +9.39% | 24.1K |
$2.07 | $49,937.61 | 280.72K |
Scheduled
|
Mar 22
| ||
Form 4
| +12.59% | 28.7K |
$1.74 | $50,038.45 | 256.62K |
Scheduled
|
Feb 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
∞
| 227.92K |
—
|
—
| 227.92K |
Apr 27 - Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SOLENO THERAPEUTICS INC (SLNO) Snapshot price: $46.36
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 6.5K |
—
|
—
| 6.5K |
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||